Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2019-07-18 Share Issue/Capital Cha…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding the pricing of an Initial Public Offering (IPO) of American Depositary Shares (ADSs). It details the share issuance, pricing, and listing on the Nasdaq Global Select Market. While it discusses capital changes, it is specifically an announcement of a new share offering and pricing, which falls under the 'Share Issue/Capital Change' category. It is not a prospectus itself, but an announcement of the pricing of the offering.
2019-07-18 English
Capital/Financing Update 2019
Capital/Financing Update Classification · 98% confidence The document is titled "Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States" and details the pricing, gross proceeds, underwriting details, and expected timeline for an IPO on the Nasdaq Global Select Market. This announcement concerns a major financing and capital structure event (issuance of new shares/ADSs). This aligns directly with the definition of 'Capital/Financing Update' (Code: CAP), which covers company fundraising and capital structure changes. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific, significant capital transaction.
2019-07-18 English
F-1MEF
Regulatory Filings
2019-07-18 English
REGISTRATION STATEMENT
Registration Form
2019-07-17 English
FWP
Regulatory Filings
2019-07-16 English
F-1/A
Regulatory Filings
2019-07-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.